The Nov. 14 piece by Megan Twohey and Christina Jewett cited three children – two 11-year-olds and a 13-year-old – who took puberty blockers. The article stated that "there is emerging evidence of potential harm from using blockers, according to reviews of scientific papers and interviews with more than 50 doctors and academic experts around the world."
This emerging evidence is causing many doctors to halt the practice of prescribing these blockers.
Framed as "safe and reversible," these medications have become the first line of intervention for young children seeking to address their gender dysphoria. But Ken Ham, the CEO of Answers in Genesis (AiG), said there is nothing safe and reversible with hormone therapies.
Ham mentioned the different health risks linked to these puberty blockers – including decreased bone density leading to easily fractured bones, osteoporosis, permanent infertility, chronic back pain and potential brain issues.
"That's just puberty blockers. That doesn't include the surgeries – like mastectomies – these children and teens are increasingly funneled into," remarked the AiG CEO. "It's a horrifying world of pain and lifelong dependence on the medical community."
"It's all very new. We don't know the long-term consequences of all of this, yet the experiments on a generation of kids enthusiastically continue."
Ultimately, Ham pointed out that even though the Times brought attention to the dangers of gender-related medical interventions, the paper is not actually against them or the bigger gender madness sweeping the culture.
"They firmly believe gender is fluid and even suggest that, despite the mounting evidence that these puberty blockers are not safe and reversible as we've always been told, the 'benefits are worth the costs.'"
One recent study said young girls who underwent breast removal surgery as they were "transitioning" into males saw an improvement in their quality of life. However, real experts slammed its findings as its three-month follow-up period was unreliable.
The said study, published Sept. 26 in the Journal of the American Medical Association (JAMA), looked at two groups of female patients aged 13 to 24 who were "transitioning" into males. One group underwent mastectomies, while the other did not. It ultimately concluded that "top surgery is associated with improved chest dysphoria, gender incongruence and body image satisfaction" in the cohort.
Experts, however, did not agree with the findings as its follow-up period only encompassed three months – a period too short to assess the real effects of this surgical procedure.
"I don't think it should shape clinical care because three months after an operation, people can easily feel happy because complications haven’t happened yet," psychotherapist Stella O'Malley told Fox News.
"What we need to know is how they feel after a year, how they feel after five years, and how they feel after 10 years. Then you’ve got something statistically significant, and you’ve got some serious data that you can actually shape your clinical care around,” she added. (Related: Horrific child abuse: Mastectomies among 'transgender' minors have 'exploded.')
"The affirmative model is only 10 years old, so we don't have any long-term data. We don’t know what the impact of a mastectomy is on a 14-year-old. We don't know what they're like when they're 24 because there isn't any data to show us."
Head over to GenderConfused.com for more stories about gender-related medical interventions.
Watch a detransitioned molecular biologist warn against puberty blockers in the news interview below.
This video is from the NewsClips channel on Brighteon.com.